×
-0.016734279918864 -0.016734279918864 -0.0238336713995943 -0.0238336713995943 -0.0603448275862068 -0.106237322515213 -0.0947008113590264 -0.0689655172413793
Stockreport

Dr. Reddy’s Q3 and 9M FY18 Financial Results

DR REDDY LABS (RDY)  More Company Research Source: Business Wire
PDF HYDERABAD, India--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the third quarter and nine months ended December 31, 2017 under International Financial Reporting Standards (IFRS). Q3 Performance Summary       9M Performance Summary Rs.3,806 Cr Rs.10,668 Cr Revenue Revenue [Up: 7% QoQ, Up: 3% YoY] [Read more]

IMPACT SNAPSHOT EVENT TIME: RDY
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS